Found: 24
Select item for more details and to access through your institution.
Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis.
- Published in:
- Journal of Neurosurgery: Spine, 2023, v. 39, n. 2, p. 278, doi. 10.3171/2023.3.SPINE221086
- By:
- Publication type:
- Article
Unmet Needs, Quality of Life, and Financial Toxicity Among Survivors of Lung Cancer.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e246872, doi. 10.1001/jamanetworkopen.2024.6872
- By:
- Publication type:
- Article
An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis.
- Published in:
- Current Oncology, 2022, v. 29, n. 6, p. 4342, doi. 10.3390/curroncol29060347
- By:
- Publication type:
- Article
Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer.
- Published in:
- BioDrugs, 2023, v. 37, n. 6, p. 775, doi. 10.1007/s40259-023-00614-5
- By:
- Publication type:
- Article
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. 971, doi. 10.1093/oncolo/oyac140
- By:
- Publication type:
- Article
Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1822, doi. 10.1002/onco.13900
- By:
- Publication type:
- Article
A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 7, p. 859, doi. 10.1634/theoncologist.2017-0465
- By:
- Publication type:
- Article
Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 627, doi. 10.1634/theoncologist.2016-0390
- By:
- Publication type:
- Article
What Lies Within: Novel Strategies in Immunotherapy for Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 11, p. 1203, doi. 10.1634/theoncologist.2013-0171
- By:
- Publication type:
- Article
Genomic Alterations in Advanced Esophageal Cancer May Lead to Subtype-Specific Therapies.
- Published in:
- Oncologist, 2013, v. 18, n. 7, p. 823, doi. 10.1634/theoncologist.2013-0130
- By:
- Publication type:
- Article
Consolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction Nomogram.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Isolated progression of metastatic lung cancer: Clinical outcomes associated with definitive radiotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 8, p. 415
- By:
- Publication type:
- Article
Immunotherapy for Mesothelioma: Rationale and New Approaches.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 9, p. 562
- By:
- Publication type:
- Article
The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2405, doi. 10.1007/s00262-022-03169-6
- By:
- Publication type:
- Article
Sex-specific differences in immunogenomic features of response to immune checkpoint blockade.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.945798
- By:
- Publication type:
- Article
Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning Evaluation.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4150, doi. 10.3390/cancers14174150
- By:
- Publication type:
- Article
Use of Immune Checkpoint Inhibitors in Mesothelioma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Systemic Treatment Options for Brain Metastases from Non-Small-Cell Lung Cancer.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 4, p. 156
- By:
- Publication type:
- Article
Managing Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2015, v. 13, n. 8, p. 528
- By:
- Publication type:
- Article
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
- Published in:
- Journal of Neurosurgery, 2022, v. 136, n. 1, p. 56, doi. 10.3171/2020.10.JNS201787
- By:
- Publication type:
- Article